| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87b47a5883053f16aa1e917293a1d0f7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2008-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ffe654bcde049e19b0ca2f2a3d6139f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_237f2f36a5b4dd4ed795ff610bd7a35c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc4cc1cd2093ca78626c26590d43b17f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02bd112c5f4ad196290f90fc24545feb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d65a691928254aedef53ff0784c8761 |
| publicationDate |
2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2696164-C |
| titleOfInvention |
Cancer treatment using humanized antibodies that bind to ephb4 |
| abstract |
In certain embodiments, this application provides humanized antibodies that bind to the EphB4 protein as well as uses of the antibodies for therapeutic purposes. The invention optionally relates to a deimmunized antibody or antigen binding fragment thereof that binds the extracellular domain of EphB4, comprising a heavy chain variable region and a light chain variable region. The heavy chain variable region comprises the sequence selected from SEQ ID NO: 13 and SEQ ID NO: 14. The light chain variable region comprises the sequence selected from SEQ ID NO: 17 and SEQ ID NO: 18. |
| priorityDate |
2007-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |